データなし
データなし
AIM Sports Group Names Randy Totorp to Advisory Board
AIM ImmunoTech Announces Notification of Noncompliance With Additional NYSE American Continued Listing Standards
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability From Incumbent Board
Aim ImmunoTech Urges Shareholders To Vote On The White Universal Proxy Card "For" All 4 Incumbent Board Members; Believes Future Of The Co And That The Current Board Is Best Positioned To Continue Clinical Trial Momentum, Commercialize Ampligen And...
AIM ImmunoTech Announced It Was Granted Patent No. 2,0832,813 Covering Ampligen For Use In Treatment Of Post-COVID Condition Of Fatigue
データなし